Dr. Kate Knobil joins the biotech as it looks to combat a viral infection that can be dangerous to patients with the lung ...

British drugmaker GSK said it was "well positioned" to respond to any potential impact from sector-specific tariffs if they ...

U.S.-listed shares of GSK are gaining in intraday trading Wednesday after the British pharma giant posted ...

Big pharmaceutical companies ... across the BBB (blood-brain barrier),” Christopher Austin, senior vice president of research technologies, GSK, said in a prepared statement.

The UK-headquartered pharma group is making £77 million ... prevalence due to the ageing of the population," said Christopher Austin, GSK's head of research technologies. "Many of the most ...

Christopher Austin, senior vice president of research technologies at GSK, said: “Many of the most promising new therapies are antibodies, which cannot efficiently reach the brain without a shuttle to ...